U.S., Feb. 4 -- An application to own the trademark for 'SK5' has been filed on Aug. 19, 2025.
Owner(s):
Skyhawk Therapeutics, Inc.; 180 3rd Avenue, Sixth Floor, , MASSACHUSETTS
Goods and/or Services:
For: Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of Huntington’s Disease
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026-02-03&serialNumber=99345538
Disclaimer: Curated by HT Syndication....